tiprankstipranks
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market
PPLPHARMA
Piramal Pharma Limited
RESEARCH TOOLSreports

Piramal Pharma Limited (PPLPHARMA) Financial Statements

11 Followers

Piramal Pharma Limited Financial Overview

Piramal Pharma Limited's market cap is currently ₹187.49B. The company's EPS TTM is ₹-0.7; its P/E ratio is -41.77; and it has a dividend yield of 0.08%. Piramal Pharma Limited is scheduled to report earnings on January 28, 2026, and the estimated EPS forecast is ₹0.92. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 90.61B₹ 81.06B₹ 70.32B₹ 64.72B₹ 29.00B
Gross Profit₹ 54.89B₹ 48.48B₹ 40.32B₹ 37.91B₹ 16.46B
Operating Income₹ 6.79B₹ 4.62B₹ -479.70M₹ 3.65B₹ 4.81B
EBITDA₹ 16.49B₹ 13.67B₹ 8.94B₹ 12.60B₹ 8.94B
Net Income₹ 911.30M₹ 178.20M₹ -1.86B₹ 3.76B₹ 5.71B
Balance Sheet
Cash & Short-Term Investments₹ 5.21B₹ 5.02B₹ 6.60B₹ 3.79B₹ 1.62B
Total Assets₹ 156.78B₹ 153.12B₹ 145.23B₹ 127.97B₹ 57.57B
Total Debt₹ 48.56B₹ 47.10B₹ 56.37B₹ 41.28B₹ 1.74B
Net Debt₹ 43.55B₹ 43.53B₹ 54.41B₹ 39.00B₹ 275.30M
Total Liabilities₹ 75.52B₹ 74.00B₹ 77.49B₹ 61.00B₹ 16.56B
Stockholders' Equity₹ 81.25B₹ 79.11B₹ 67.73B₹ 66.97B₹ 41.01B
Cash Flow
Free Cash Flow₹ 2.28B₹ 2.92B₹ -4.81B₹ -1.23B₹ -233.90M
Operating Cash Flow₹ 8.92B₹ 10.05B₹ 4.84B₹ 7.66B₹ 347.20M
Investing Cash Flow₹ -4.77B₹ -4.34B₹ -13.39B₹ -18.12B₹ -43.83B
Financing Cash Flow₹ -4.41B₹ -4.22B₹ 8.18B₹ 7.94B₹ 44.94B
Currency in INR

Piramal Pharma Limited Earnings and Revenue History

Income Statement >

Piramal Pharma Limited Debt to Assets

Balance Sheet >

Piramal Pharma Limited Cash Flow

Cash Flow >

Piramal Pharma Limited Forecast EPS vs Actual EPS

Earnings >